Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Voydeya Recommended for EU Marketing Authorization as PNH Treatment Add-On

(IN BRIEF) Voydeya (danicopan), a first-in-class oral Factor D inhibitor, has been recommended for marketing authorization in the European Union (EU) as an add-on to ravulizumab or eculizumab for adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who experience residual haemolytic … Read the full press release

GSK’s Gepotidacin Shows Promise as Gonorrhoea Treatment: Positive Results from EAGLE-1 Trial

(IN BRIEF) GSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, an oral antibiotic aimed at treating uncomplicated urogenital gonorrhoea in adolescents and adults. The trial demonstrated gepotidacin’s non-inferiority compared to the current … Read the full press release

Boosting Grenada’s Healthcare: CDB and EIB Announce Major Funding Initiative

(IN BRIEF) Grenada’s healthcare infrastructure is set to undergo a significant transformation with a US$ 9,970,500 loan from the Caribbean Development Bank (CDB), financed by the European Investment Bank (EIB). The project, launched in St. George’s, Grenada, aims to strengthen … Read the full press release

Boehringer Ingelheim’s Survodutide Shows Promising Results as Potential Best-in-Class Treatment for MASH in Phase II Trial

(IN BRIEF) Boehringer Ingelheim has reported compelling results from its Phase II trial of Survodutide, a novel glucagon/GLP-1 receptor dual agonist, indicating its potential to become a leading treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH). In the trial, up to 83.0% … Read the full press release

ZEISS and University of Oxford Collaborate to Advance Biomedical Imaging

(IN BRIEF) The University of Oxford and ZEISS have inaugurated the Oxford-ZEISS Centre of Excellence in Biomedical Imaging, promising cutting-edge microscopy and imaging technologies to further research in global health and disease. This collaboration between the Kennedy Institute of Rheumatology, … Read the full press release

Comprehensive Review in The Lancet Explores Atrial Fibrillation Risk Factors and Management

(IN BRIEF) A recent comprehensive review published in The Lancet Regional Health Europe offers insights into the risk factors and management strategies for atrial fibrillation (AF), a prevalent heart rhythm disorder affecting millions globally. Conducted by researchers from the University … Read the full press release

ETZ Hospital Secures €115 Million Financing for Modernization and Sustainability Drive

(IN BRIEF) ETZ hospital has finalized a €115 million financing deal with the European Investment Bank (EIB) and BNG Bank to support the modernization of its St. Elisabeth location in Tilburg. This funding will facilitate the construction of a new … Read the full press release

The latest on quantum computing in Europe, January 2023 – February 2024

(IN BRIEF) Europe has made significant progress in quantum computing with investments, partnerships, and innovations. Highlights include a €3.5 million investment in LioniX International by the University of Twente, and T-Systems offering cloud access to IBM’s quantum systems. Other developments … Read the full press release

Novo Nordisk Announces Annual General Meeting Date and Proposals for Board Re-election

(IN BRIEF) Novo Nordisk A/S has announced the date for its Annual General Meeting, scheduled for Thursday, March 21, 2024, at 14:00 CET. The meeting will be held partially electronically, allowing shareholders to participate either in person at Bella Center … Read the full press release

Bristol Veterinary School Marks 75 Years of Leading Veterinary Medicine and Conservation

(IN BRIEF) In 2024, the University of Bristol’s Veterinary School commemorates 75 years of excellence in educating veterinary professionals and spearheading advancements in veterinary science. Established in 1949 following recommendations from the Loveday Committee, the school has evolved into a … Read the full press release

Fresenius Projects Robust Earnings Growth in 2024 Following Successful 2023

(IN BRIEF) Fresenius had a strong finish in 2023, with a robust fourth quarter performance. They project accelerated earnings growth in 2024 due to the momentum from their #FutureFresenius initiatives. Achieving their raised outlook for FY/23, the company saw continued … Read the full press release

Innovative TU/e Master’s Student Creates SUWEVE to Enhance Wheelchair Mobility

(IN BRIEF) Wouter Witteman, a master’s student in Embedded Systems at Eindhoven University of Technology (TU/e), is known for his innovative solutions. His latest venture, SUWEVE, aims to improve wheelchair mobility by allowing users to face backward while being pushed. … Read the full press release

Evonik to Introduce New Class of rPEG Lipids for Enhanced Immunogenicity in Drug Delivery

(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release

Philips Nominates New Members to Supervisory Board, Continues Focus on Healthcare Innovation

(IN BRIEF) Royal Philips, a prominent player in health technology, proposes the re-appointment of Chairman Feike Sijbesma and Peter Löscher to its Supervisory Board, along with the appointment of Benoît Ribadeau-Dumas as a new member. The nominations, to be voted … Read the full press release

Higher Education Leaders Call for Ministerial Taskforce to Address Decline in Healthcare Course Applications

(IN BRIEF) In response to the latest UCAS data indicating a decline in applications for medicine, nursing, and midwifery courses, leaders from various higher education groups are urging the government to establish a ministerial taskforce. This taskforce would facilitate collaboration … Read the full press release

AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan Moves Closer to Approval for Advanced NSCLC Treatment

(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted by the FDA for the treatment of locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) in patients who have undergone prior … Read the full press release

AstraZeneca’s Tagrisso Shows Promise in Phase III LAURA Trial for EGFR-Mutated Lung Cancer

(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) demonstrates significant improvement in progression-free survival (PFS) for patients with unresectable, Stage III EGFR-mutated non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT) in the LAURA Phase III trial. The trial, led by Dr. Suresh Ramalingam, … Read the full press release

FDA Approves AstraZeneca’s Tagrisso Plus Chemotherapy for EGFR-Mutated Lung Cancer

(IN BRIEF) AstraZeneca’s Tagrisso receives FDA approval for treating adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) following a Priority Review. The decision is based on FLAURA2 Phase III trial results demonstrating that Tagrisso plus … Read the full press release

Almirall Achieves Robust Growth in Dermatology Sector, Expands Pipeline with Licensing Agreement

(IN BRIEF) Almirall, a leading biopharmaceutical company specializing in medical dermatology, has reported its full-year 2023 financial results, showcasing a 4% year-on-year growth in net sales driven by the strong performance of its European Dermatology business. The company’s total EBITDA … Read the full press release

Almirall Secures Global Rights for Promising Dermatological Treatment, NN-8828, Targeting IL-21

(IN BRIEF) Almirall S.A., a leading pharmaceutical company specializing in medical dermatology, has finalized an exclusive license agreement with Novo Nordisk for the development and commercialization of NN-8828, an IL-21 blocking monoclonal antibody. This innovative treatment holds potential for various … Read the full press release

Dupixent® Receives Landmark Approval in Japan for Chronic Spontaneous Urticaria Treatment

(IN BRIEF) Japan’s Ministry of Health, Labor and Welfare (MHLW) has authorized the marketing and manufacturing of Dupixent® (dupilumab) for treating chronic spontaneous urticaria (CSU) in patients aged 12 years and older. This approval marks a significant milestone as Japan … Read the full press release

Newcastle University Lecturer Honored with National Award for Surgical Innovation

(IN BRIEF) Dr. Kenneth Rankin, an honorary senior lecturer at Newcastle University, was bestowed with the prestigious Researcher of the Year award at The Bone Idols 2024 ceremony for his outstanding contributions to surgical oncology. Recognized for his remarkable innovation … Read the full press release

UEA Launches £1.1 Million Project to Enhance Mental Health Support for Teens in Care

(IN BRIEF) The University of East Anglia (UEA) embarks on “LIMITLESS II,” a £1.1 million endeavor funded by the National Institute for Health and Care Research (NIHR), aimed at enhancing mental health support for teenagers living in care. Led by … Read the full press release

Rheinmetall’s Joint Venture Secures Major Healthcare Sector Order for Innovative Fatigue Detection System

(IN BRIEF) Rheinmetall Dermalog SensorTec GmbH, a joint venture between Rheinmetall AG and DERMALOG Identification Systems GmbH, has clinched a significant order from a leading healthcare company for a cutting-edge system designed to detect distraction and fatigue during final quality … Read the full press release

GSK Expands Respiratory Biologics Portfolio with Aiolos Bio Acquisition

(IN BRIEF) GSK plc has finalized the acquisition of Aiolos Bio, bolstering its respiratory biologics portfolio with AIO-001, a promising long-acting anti-TSLP monoclonal antibody for treating asthma. AIO-001, set to enter phase II clinical trials, targets severe asthma patients with … Read the full press release

Sweco Leads Sustainable Südspidol Hospital Complex Project in Luxembourg

(IN BRIEF) Sweco, a leading technology consulting firm, will lead a consortium tasked with developing the new Südspidol hospital complex in Esch-sur-Alzette, Luxembourg, scheduled for full operation by 2033. Partnering with Centre Hospitalier Emile Mayrisch (CHEM), Sweco will oversee the … Read the full press release

DNV and Renji Hospital Extend Successful Collaboration into Seventh Year, Reinforcing Commitment to Medical Quality Certification

(IN BRIEF) DNV and Renji Hospital in Shanghai proudly announce the renewal of their partnership, continuing their successful collaboration into its seventh year. Renji Hospital’s international department has actively participated in DNV’s International Medical Quality Certification Programme since 2017, aiming … Read the full press release


(IN BRIEF) From Bonn to Bilbao, Europe’s AI scene is buzzing with innovation. Major players like Deutsche Telekom, Ericsson, and Volkswagen are pushing boundaries through groundbreaking partnerships and integrations. Projects like NextGen are personalizing therapies using AI, while collaborations between … Read the full press release

GSK’s Bepirovirsen Receives FDA Fast Track Designation for Chronic Hepatitis B Treatment

(IN BRIEF) GSK plc has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for bepirovirsen, an investigational antisense oligonucleotide (ASO) targeting chronic hepatitis B (CHB). The Fast Track designation aims to expedite the development … Read the full press release

New Method Traces Pre-existing Resistance in Cancer Cells, Opening Doors for Targeted Therapies

(IN BRIEF) A recent study published in Nature Communications by researchers at the University of Helsinki introduces a groundbreaking methodology called ReSisTrace, designed to identify and trace pre-existing treatment resistance in cancer cells. By labeling cancer cells with genetic barcodes … Read the full press release

NextGen Initiative: Advancing Cardiovascular Healthcare Through AI-Personalized Therapies

(IN BRIEF) The NextGen project, funded by the EU’s Horizon Europe program with €7.6 million, has commenced in Utrecht, the Netherlands. Led by a 21-member consortium including the European Society of Cardiology, the project aims to personalize therapies for patients … Read the full press release

Lensa, един от най-ценените търговци на оптика в Румъния, пристига в България. Първият шоурум е открит в София

(НАКРАТКО) Lensa, известен търговец на оптика в Румъния, разширява присъствието си в региона, откривайки първия си магазин в България, конкретно в София. Магазинът предлага широка гама от очила и слънчеви очила на водещи марки, като Ray Ban, Police, Furla и … Read the full press release

University of Liverpool Appoints New Chair of Oncology to Tackle Rising Cancer Incidence in Liverpool City Region

(IN BRIEF) As World Cancer Day approaches, the University of Liverpool has appointed Professor Tim Maughan as the Chair of Oncology to address the growing cancer incidence in the Liverpool City Region. With a focus on improving outcomes through immunotherapy … Read the full press release

Report Reveals Crisis in Autism Assessment for Children, Urging a ‘Needs-Led’ Approach

(IN BRIEF) A report by the Child of the North initiative, led by the N8 Research Partnership and former Children’s Commissioner Anne Longfield’s Centre for Young Lives think tank, has unveiled a crisis in autism assessments for children, with many … Read the full press release

AF Gruppen Nominated as Contractor for New Rikshospitalet Temporary Facilities in Oslo

(IN BRIEF) AF Gruppen has received a nomination from the South-Eastern Norway Regional Health Authority to serve as the contractor for the construction of temporary office and accommodation facilities at the New Rikshospitalet (Oslo University Hospital) located in Gaustad, Oslo. … Read the full press release

NIDUS-Family Therapy Shows Promise in Helping People with Dementia Achieve Personal Goals

(IN BRIEF) A recent study led by Queen Mary University of London, in collaboration with the University of Exeter, highlights the efficacy of a new therapy called NIDUS-Family in assisting individuals with dementia and their family carers in achieving their … Read the full press release

Acoramidis Shows Positive Results in Japanese Trial for Treating Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

(IN BRIEF) In a Phase III trial conducted in Japan, acoramidis, an investigational treatment for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), demonstrated promising high-level results consistent with the global BridgeBio Pharma, Inc. ATTRibute-CM Phase III trial. The trial in Japan aimed to … Read the full press release

The Future of Cancer Detection: Multi-Cancer Blood Tests Raise Hope and Questions

(IN BRIEF) Multi-cancer early detection (MCED) blood tests hold the promise of revolutionizing cancer screening by providing a comprehensive, minimally invasive screening option for multiple types of cancer in a single blood sample. These tests offer the potential to increase … Read the full press release

BASF Announces Leadership Changes in Nutrition and Health Divisions

(IN BRIEF) BASF has announced leadership changes in its Nutrition and Health divisions. Julia Raquet will assume responsibility for the Division Europe, Middle East, and Africa, while Dr. Martin Volland will take charge of the Division Nutrition & Health. These … Read the full press release

Aviva Research Highlights Need for Greater Awareness of Healthy Lifestyles and Cancer Prevention

(IN BRIEF) New research by Aviva reveals that there is still a need to raise awareness about the importance of leading a healthy lifestyle in cancer prevention. Over half of those surveyed hope cancer won’t happen to them, and 20% … Read the full press release